Sign In
17 Feb 2015 07:00
For immediate release 17 February 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Directorate Change
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that Richard Wright has informed the Board of his intention to leave the Company, after nearly eight years as Finance Director, to pursue other opportunities. Richard will remain in his role until 31 May 2015.
A search process for a new Finance Director has commenced and the Company will provide an update on this in due course.
John Dawson, Alliance Pharma's Chief Executive, commented: "I have enjoyed working with Richard and warmly thank him for the very significant contribution he has made to Alliance's development over these past several years. On behalf of the entire Board I wish him well with his future endeavours."
For further information:
Alliance Pharma plc | + 44 (0) 1249 466966 |
John Dawson, Chief Executive | |
Richard Wright, Finance Director | |
www.alliancepharma.co.uk | |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Sophie Cowles / Jane Glover | |
Numis Securities Limited | + 44 (0) 20 7260 1000 |
Nominated Adviser: Michael Meade / Freddie Barnfield | |
Corporate Broking: David Poutney |
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
Follow the stocks
